Ladenburg Thalmann Financial Services’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-8,506
| Closed | -$39K | – | 5564 |
|
|
2019
Q1 | $39K | Buy |
8,506
+1,216
| +17% | +$5.76K | ﹤0.01% | 3584 |
|
|
2018
Q4 | $25K | Buy |
7,290
+42
| +0.6% | +$292 | ﹤0.01% | 3743 |
|
|
2018
Q3 | $73K | Buy |
7,248
+3,991
| +123% | +$31.8K | ﹤0.01% | 3072 |
|
|
2018
Q2 | $20K | Hold |
3,257
| – | – | ﹤0.01% | 3841 |
|
|
2018
Q1 | $20K | Sell |
3,257
-5,255
| -62% | -$43.4K | ﹤0.01% | 3841 |
|
|
2017
Q4 | $82K | Buy |
8,512
+6,444
| +312% | +$42.2K | ﹤0.01% | 2866 |
|
|
2017
Q3 | $19K | Buy |
2,068
+533
| +35% | +$5.5K | ﹤0.01% | 3724 |
|
|
2017
Q2 | $19K | Sell |
1,535
-1
| -0.1% | -$12 | ﹤0.01% | 3669 |
|
|
2017
Q1 | $17K | Buy |
1,536
+1,038
| +208% | +$11.1K | ﹤0.01% | 3674 |
|
|
2016
Q4 | $4K | Sell |
498
-675
| -58% | -$7.63K | ﹤0.01% | 4364 |
|
|
2016
Q3 | $13K | Sell |
1,173
-1,262
| -52% | -$19.2K | ﹤0.01% | 3684 |
|
|
2016
Q2 | $33K | Buy |
2,435
+165
| +7% | +$2.4K | ﹤0.01% | 3006 |
|
|
2016
Q1 | $38K | Buy |
2,270
+500
| +28% | +$9.5K | ﹤0.01% | 2804 |
|
|
2015
Q4 | $50K | Sell |
1,770
-3,535
| -67% | -$97.9K | ﹤0.01% | 2558 |
|
|
2015
Q3 | $150K | Buy |
5,305
+3,024
| +133% | +$111K | ﹤0.01% | 1703 |
|
|
2015
Q2 | $81K | Buy |
2,281
+347
| +18% | +$10.8K | ﹤0.01% | 2252 |
|
|
2015
Q1 | $57K | Buy |
1,934
+222
| +13% | +$5.87K | ﹤0.01% | 2460 |
|
|
2014
Q4 | $37K | Buy |
1,712
+1,688
| +7,033% | +$33.4K | ﹤0.01% | 2554 |
|
|
2014
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 4095 |
|
|
2014
Q2 | $0 | Sell |
24
-4,500
| -99% | -$72.7K | ﹤0.01% | 4035 |
|
|
2014
Q1 | $94K | Hold |
4,524
| – | – | ﹤0.01% | 1539 |
|
|
2013
Q4 | $58K | Buy |
4,524
+4,500
| +18,750% | +$62.4K | ﹤0.01% | 1819 |
|
|
2013
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 3885 |
|
|
2013
Q2 | $0 | Buy |
+24
| New | +$88 | ﹤0.01% | 3715 |
|
Other funds holding INSY
WS
Ladenburg Thalmann Financial Services's INSY Position: Q2 2019 in Review
Ladenburg Thalmann Financial Services sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 8,506 shares — an estimated $39K sold.
Ladenburg Thalmann Financial Services first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $150K in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Ladenburg Thalmann Financial Services reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Ladenburg Thalmann Financial Services sold 8,506 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $39K.
- Ladenburg Thalmann Financial Services first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Ladenburg Thalmann Financial Services's Insys Therapeutics, Inc. position peaked at $150K in Q3 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2019, filed 15 Aug 2019.